Cipher Pharmaceuticals Inc. (CPHRF)
OTCMKTS · Delayed Price · Currency is USD
10.60
+0.05 (0.50%)
Oct 16, 2025, 1:23 PM EDT
Cipher Pharmaceuticals Market Cap
Cipher Pharmaceuticals has a market cap or net worth of $262.30 million as of October 16, 2025. Its market cap has decreased by -9.13% in one year.
Market Cap
262.30M
Enterprise Value
276.02M
Revenue
47.59M
Ranking
n/a
PE Ratio
21.60
Stock Price
$10.60
Market Cap Chart
Since February 25, 2004, Cipher Pharmaceuticals's market cap has increased from 58.00M to 262.30M, an increase of 352.27%. That is a compound annual growth rate of 7.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2025 | 262.30M | 2.99% |
| Dec 31, 2024 | 254.68M | 152.73% |
| Dec 29, 2023 | 100.77M | 41.37% |
| Dec 30, 2022 | 71.28M | 94.22% |
| Dec 31, 2021 | 36.70M | 86.01% |
| Dec 31, 2020 | 19.73M | -36.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 749.94M |
| Elite Pharmaceuticals | 652.54M |
| Veradigm | 514.01M |
| Nika Pharmaceuticals | 495.49M |
| Northwest Biotherapeutics | 360.44M |
| CytoDyn | 350.21M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 275.85M |